62 results
Page 3 of 4
SUPPL
9x5tes5hsz9wt7b22fn
9 Dec 19
Supplemental materials (foreign)
6:35am
6-K
EX-99.2
cudb81m2370r 6th0r
14 Nov 19
Current report (foreign)
4:05pm
6-K
EX-99.1
x4xhl23ky37gu
14 Nov 19
Current report (foreign)
4:05pm
6-K
EX-99.1
czu nfxyi8wgqwwkv
13 Sep 19
Open Market Sale Agreementsm
5:28pm
SUPPL
x0ysz77 w99
13 Sep 19
Supplemental materials (foreign)
5:05pm
6-K
EX-99.2
iz4fc64aplci3fri95
6 Aug 19
Current report (foreign)
4:06pm
6-K
EX-99.3
d3gossez6
6 Aug 19
Current report (foreign)
4:06pm
6-K
EX-99.4
vzm6s11st6nx8aenstr
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
EX-99.2
731mj9nxuzi
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
EX-99.2
xwt1 vi73pv9snh536k5
14 May 19
Current report (foreign)
4:04pm
6-K
EX-99.1
3aksr
14 May 19
Current report (foreign)
4:04pm
6-K
EX-99.1
fwqombizrw k5tqosotx
14 May 19
Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights
4:02pm
6-K
EX-99.1
hmt4d
30 Apr 19
Aurinia Further Strengthens Its Board of Directors with the Appointment of Dr. Daniel Billen
6:05am
6-K
EX-99.1
63t qqsoa
11 Apr 19
Aurinia Pharmaceuticals Inc. 6-K
4:39pm
40-F
EX-99.1
hag2wuvnp9fyfj5c
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.2
6r3 ygz7dkrm
30 Nov 18
Current report (foreign)
5:27pm
SUPPL
x4ua1v
30 Nov 18
Supplemental materials (foreign)
5:23pm
6-K
EX-99.1
hzu3su
8 Nov 18
Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development
4:02pm
6-K/A
EX-99.3
9fkx m7nfu3dfxc
17 May 18
Current report (foreign) (amended)
12:00am
40FR12B/A
EX-99.37
i1557f8p4jd27sxfb
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am